Pharmaceutical composition comprising a monoamine neurotransmitter reuptake inhibitor and an Nmethyl-D-aspartate (NMDA) receptors antagonist

Details for Australian Patent Application No. 2005205882 (hide)

Owner NeuroSearch A/S

Inventors Mierau, Joachim; Raschig, Andreas; Friedl, Thomas; Reess, Juergen

Agent Davies Collison Cave

Pub. Number AU-A-2005205882

PCT Pub. Number WO2005/070429

Priority 04005818.2 11.03.04 EP; 04001283.3 22.01.04 EP

Filing date 11 January 2005

Wipo publication date 4 August 2005

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070429 Priority application(s): WO2005/070429

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205887-Solid dosage form

2005205880-Compounds for the sustained reduction of body weight